{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003812","form_type":"8-K","ticker":"SCNX","cik":"0001382574","company_name":"Scienture Holdings, Inc.","filed_at":"2025-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.113605+00:00","generated_at":"2026-05-23T15:58:29.863766+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Scienture divests IPS and Bonum to Tollo for $5M note; focuses on Specialty Pharma","bullets":["Total consideration is $5M in a promissory note bearing interest at prime rate, maturing June 30, 2030.","Closing expected June 30, 2025; Tollo must pay 20% of future equity proceeds toward the note.","CEO Suren Ajjarapu and President Prashant Patel have beneficial interest in buyer Tollo (related party).","Proceeds will fund high-growth product development at Scienture, LLC subsidiary.","Divestiture includes legacy Healthcare IT (IPS, Bonum, Softell) to streamline operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003812","json":"https://secwatch.observer/filing/0001641172-25-003812.json","markdown":"https://secwatch.observer/filing/0001641172-25-003812.md","text":"https://secwatch.observer/filing/0001641172-25-003812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382574/000164117225003812/0001641172-25-003812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382574/000164117225003812/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T15:58:29.863766+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}